After scrapping plans for an IPO in 2022, Hinge Health Inc. is taking a more favorable view of going public given the increased support seen for health care and med-tech stocks in recent months. The ...

Hinge Health files IPO with CEO Daniel Perez holding 19% voting power. Major clients include HCSC, Elevance Health & Aetna.

Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.

The digital health IPO market has slowed to a crawl in recent years, but it could be poised for a turnaround in 2025, experts ...

South Side-based biotech firm Carmell Corp. announced a comprehensive corporate rebrand and will now operate under the new ...

San Francisco-based Hinge Health grew its revenues by a third to nearly $400 million last year. Its customer base include ...

Digital physical therapy company Hinge Health filed to go public Monday, signaling a potential revival of the dormant digital ...

Teladoc Health is offering fertility, digestive health, and specialty care to its enterprise customers, the company said ...

Wall Street is working to usher a highly-anticipated group of companies to the public markets, but rampant volatility and a ...

Physical therapy startup Hinge Health just filed to go public. These are the most important takeaways from its S-1.

IP Group portfolio company Hinge Health has filed with the US market regulator to go public on the New York Stock Exchange.

Hinge Health was valued at $6.2 billion during a 2021 funding round and reported 33.4% revenue growth last year, according to Reuters. The company reported net losses dropped from $108.1 million in ...